S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: China Resources [600062.SS]

交易所: SHH 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
最后更新时间26 Apr 2024 @ 15:00

-0.84% CNY 21.20

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:00):

China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its subsidiaries, operates as a pharmaceutical company in the People's Republic of China...

Stats
今日成交量 12.54M
平均成交量 11.09M
市值 21.97B
EPS CNY0.295 ( 2023-10-26 )
Last Dividend CNY0 ( N/A )
Next Dividend CNY0 ( N/A )
P/E 15.82
ATR14 CNY0.0260 (0.12%)

音量 相关性

長: -0.48 (neutral)
短: 0.17 (neutral)
Signal:(53.407) Neutral

China Resources 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

China Resources 相关性 - 货币/商品

The country flag 0.27
( neutral )
The country flag 0.10
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.15
( neutral )
The country flag -0.28
( neutral )

China Resources 财务报表

Annual 2023
营收: CNY10.09B
毛利润: CNY5.14B (50.96 %)
EPS: CNY1.300
FY 2023
营收: CNY10.09B
毛利润: CNY5.14B (50.96 %)
EPS: CNY1.300
FY 2022
营收: CNY9.45B
毛利润: CNY5.22B (55.20 %)
EPS: CNY1.140
FY 2021
营收: CNY9.11B
毛利润: CNY5.08B (55.77 %)
EPS: CNY0.897

Financial Reports:

No articles found.

China Resources

China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its subsidiaries, operates as a pharmaceutical company in the People's Republic of China. The company offers soft bag, plastic and glass bottle, inner sealed polypropylene, and polypropylene blend bag infusion products; levofloxacin methylate, ambroxol hydrochloride glucose, fructose, invert sugar, hydroxyethyl starch, sodium chloride injection products, etc.; and peritoneal dialysate, hemodialysis dialysate, etc. It also provides compound reserpine triamterene tablets, pitavastatin calcium tablets, telmisartan capsules, suppository capsules, banidipine hydrochloric acid sustained-release capsules, edaravone, and other products to treat cardiovascular and cerebrovascular diseases. In addition, the company offers products for endocrinology; and pediatric compound amino acid injection, and other drugs to treat pediatrics. Further, it provides nutritional drugs, including vitamin E and C; and anti-infective drugs. The company is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. is a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。